Free Trial

Mangoceuticals (MGRX) Competitors

Mangoceuticals logo
$1.82 +0.26 (+16.29%)
As of 04/14/2025 04:00 PM Eastern

MGRX vs. CCM, MRAI, ENZ, BRTX, KDLY, ATPC, SSY, OTRK, DHAC, and ATIP

Should you be buying Mangoceuticals stock or one of its competitors? The main competitors of Mangoceuticals include Concord Medical Services (CCM), Marpai (MRAI), Enzo Biochem (ENZ), BioRestorative Therapies (BRTX), Kindly MD (KDLY), Agape ATP (ATPC), SunLink Health Systems (SSY), Ontrak (OTRK), Digital Health Acquisition (DHAC), and ATI Physical Therapy (ATIP). These companies are all part of the "healthcare" industry.

Mangoceuticals vs.

Concord Medical Services (NYSE:CCM) and Mangoceuticals (NASDAQ:MGRX) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, earnings, profitability, media sentiment, community ranking and analyst recommendations.

Concord Medical Services received 197 more outperform votes than Mangoceuticals when rated by MarketBeat users.

CompanyUnderperformOutperform
Concord Medical ServicesOutperform Votes
197
59.16%
Underperform Votes
136
40.84%
MangoceuticalsN/AN/A

56.7% of Mangoceuticals shares are held by institutional investors. 46.5% of Concord Medical Services shares are held by insiders. Comparatively, 16.0% of Mangoceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Mangoceuticals had 3 more articles in the media than Concord Medical Services. MarketBeat recorded 3 mentions for Mangoceuticals and 0 mentions for Concord Medical Services. Mangoceuticals' average media sentiment score of 1.64 beat Concord Medical Services' score of 0.00 indicating that Mangoceuticals is being referred to more favorably in the news media.

Company Overall Sentiment
Concord Medical Services Neutral
Mangoceuticals Very Positive

Mangoceuticals has lower revenue, but higher earnings than Concord Medical Services.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Concord Medical Services$471.70M0.04-$41.93MN/AN/A
Mangoceuticals$615.87K15.28-$9.21M-$4.85-0.38

Concord Medical Services has a net margin of 0.00% compared to Mangoceuticals' net margin of -1,237.00%. Concord Medical Services' return on equity of 0.00% beat Mangoceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Concord Medical ServicesN/A N/A N/A
Mangoceuticals -1,237.00%-138.00%-118.88%

Concord Medical Services has a beta of -0.64, meaning that its share price is 164% less volatile than the S&P 500. Comparatively, Mangoceuticals has a beta of 2.41, meaning that its share price is 141% more volatile than the S&P 500.

Summary

Concord Medical Services and Mangoceuticals tied by winning 6 of the 12 factors compared between the two stocks.

Remove Ads
Get Mangoceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for MGRX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MGRX vs. The Competition

MetricMangoceuticalshealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ Exchange
Market Cap$9.41M$2.02B$5.35B$7.58B
Dividend YieldN/A7.14%5.11%4.33%
P/E Ratio-0.3115.0421.6517.79
Price / Sales15.283.84375.8994.27
Price / CashN/A9.3238.1534.64
Price / Book3.374.166.443.99
Net Income-$9.21M$87.49M$3.20B$247.24M
7 Day Performance13.75%-0.76%6.67%5.84%
1 Month Performance-53.45%-8.67%-6.27%-5.78%
1 Year Performance-96.66%-27.10%8.56%-1.99%

Mangoceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MGRX
Mangoceuticals
0.6589 of 5 stars
$1.82
+16.3%
N/A-96.7%$9.41M$615,873.00-0.313Short Interest ↑
Gap Down
CCM
Concord Medical Services
N/A$4.20
-5.4%
N/A-33.0%$18.23M$471.70M0.00970Upcoming Earnings
Gap Down
MRAI
Marpai
N/A$1.00
+4.2%
N/A-55.2%$14.90M$34.87M-0.38150Gap Up
ENZ
Enzo Biochem
N/A$0.28
-2.4%
N/A-70.5%$14.83M$29.09M0.00520High Trading Volume
BRTX
BioRestorative Therapies
3.4755 of 5 stars
$1.70
-0.3%
$18.00
+961.9%
+32.8%$12.72M$377,000.00-1.117Short Interest ↓
Gap Down
KDLY
Kindly MD
0.6429 of 5 stars
$1.43
-3.4%
N/AN/A$8.62M$2.72M-2.17N/APositive News
ATPC
Agape ATP
1.0231 of 5 stars
$1.54
+26.2%
N/A-70.7%$6.15M$1.32M-2.1140Gap Down
SSY
SunLink Health Systems
N/A$0.86
-2.5%
N/A+23.4%$6.02M$31.23M6.111,376
OTRK
Ontrak
2.8112 of 5 stars
$1.43
-1.8%
$45.00
+3,057.9%
-71.6%$6.01M$11.24M-0.13250Earnings Report
Short Interest ↓
DHAC
Digital Health Acquisition
N/A$1.14
-4.2%
N/A-91.3%$4.11MN/A0.002,021
ATIP
ATI Physical Therapy
N/A$0.89
-4.3%
N/A-75.6%$3.94M$741.86M-0.055,600Gap Down
Remove Ads

Related Companies and Tools


This page (NASDAQ:MGRX) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners